🔎 Trials Near Me

Beranda › Kanker Endometrium › Colorado › Aurora

Uji klinis Kanker Endometrium di Aurora, CO

14 studi untuk Kanker Endometrium mencari peserta di lokasi sekitar Aurora (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Menerima pesertaFase 2
  • UCHealth University of Colorado Hospital, Aurora
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Menerima pesertaFase 3
  • UCHealth University of Colorado Hospital, Aurora
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07198074

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Menerima pesertaFase 2
  • UCHealth University of Colorado Hospital, Aurora
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • University of Colorado Cancer Center, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Menerima pesertaFase 1
  • University of Colorado Cancer Center, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Menerima pesertaFase 1/2
  • GSK Investigational Site, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07213609

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • University of Colorado, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • Children's Hospital Colorado, Aurora
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Menerima pesertaFase 1/2
  • Research Site, Aurora
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Menerima pesertaFase 2
  • University of Colorado, Aurora
Usia 18 ke atas · Wanita · Diperbarui 21 Agu 2026 · NCT05548296

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • University of Colorado, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Colorado Cancer Center, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Menerima pesertaFase 1/2
  • University of Colorado Cancer Center, Aurora
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Nov 2025 · NCT05902988

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Aurora
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Endometrium di kota lain

Studi lain di Aurora

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.